|
ZNF140 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64157576421076E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51141338228445E-12 |
| Normal-vs-Stage2 |
1.94439999989804E-07 |
| Normal-vs-Stage3 |
3.77808895279941E-13 |
| Normal-vs-Stage4 |
6.86189993714947E-11 |
| Stage1-vs-Stage2 |
9.239800E-01 |
| Stage1-vs-Stage3 |
3.413800E-02 |
| Stage1-vs-Stage4 |
3.274200E-02 |
| Stage2-vs-Stage3 |
1.922960E-01 |
| Stage2-vs-Stage4 |
1.307160E-01 |
| Stage3-vs-Stage4 |
6.371600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32782673745169E-13 |
| Normal-vs-AfricanAmerican |
3.89670000000564E-06 |
| Normal-vs-Asian |
1.22869999952258E-07 |
| Caucasian-vs-AfricanAmerican |
8.123800E-01 |
| Caucasian-vs-Asian |
4.257600E-01 |
| AfricanAmerican-vs-Asian |
4.635800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22150001224952E-09 |
| Normal-vs-Female |
1.63347113613099E-12 |
| Male-vs-Female |
1.493400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.40321129452559E-12 |
| Normal-vs-Age(41-60Yrs) |
6.1988192356921E-12 |
| Normal-vs-Age(61-80Yrs) |
1.89199766964521E-11 |
| Normal-vs-Age(81-100Yrs) |
1.903790E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.879800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.110770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.656400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.175800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.105400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.837400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.420600E-04 |
| Classical-VS-Follicular |
6.610200E-01 |
| Classical-VS-Other |
6.016800E-01 |
| Classical-VS-Normal |
4.32864855071102E-12 |
| Tall-VS-Follicular |
3.556800E-03 |
| Tall-VS-Other |
2.104400E-02 |
| Tall-VS-Normal |
2.01716421344145E-12 |
| Follicular-VS-Other |
5.803600E-01 |
| Follicular-VS-Normal |
5.94029999634316E-08 |
| Other-VS-Normal |
3.864300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87561077780174E-12 |
| Normal-vs-N1 |
1.33990000206197E-08 |
| N0-vs-N1 |
7.264400E-01 |
|
|
